Adult Weight Change and Risk of Postmenopausal Breast Cancer

By E. Barrett-Connor, L. Mosca, P. Collins, M. Geiger, D. Grady, M. Kornitzer, M. McNabb, N. Wenger. New England Journal of Medicine, 2006

756 citations recorded by the source corpus.

Subfields: Genetics

View Paper: https://www.semanticscholar.org/paper/271cc1624b3ff8a30cc7e1c0664f98412c6271eb

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Jianmin Jiang
2. W. Shi
3. Yi-Sheng Sun
4. Zhi-yong Zhu
5. P. Yao
6. Hanping Zhu
7. Hangjing Lu
8. Fang Xu

Citations in the corpus

• Risk Factors and Preventions of Breast Cancer (2017, background): “Raloxifene, a second generation of SERMs with fewer side-effects than TAM, has been approved for the treatment of invasive breast cancer in postmenopausal women as well as osteoporosis and heart disease [101].”